Cargando…
Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer
BACKGROUND/AIM: To explore the therapeutic effects of thymidine kinase (TK) expressed by enhanced vector pGL3-basic- hTERTp-TK-EGFP-CMV driven by human telomerase reverse transcriptase promoter (hTERTp) as well as cytomegalovirus immediate early promoter enhancer (CMV). MATERIALS/METHODS: Enhanced T...
Autores principales: | Shen, Cong-Xiang, Wen, Zhong, Qian, Yu-Hong, Mu, Shao-Feng, Guan, Xiao-Fang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917418/ https://www.ncbi.nlm.nih.gov/pubmed/20626878 http://dx.doi.org/10.1186/1756-9966-29-94 |
Ejemplares similares
-
Fusion Enzymes Containing HSV-1 Thymidine Kinase Mutants and Guanylate Kinase Enhance Prodrug Sensitivity In Vitro and In Vivo
por: Ardiani, Andressa, et al.
Publicado: (2009) -
A GSDMB enhancer-driven HSV thymidine kinase-expressing vector for controlling occult peritoneal dissemination of gastric cancer cells
por: Saeki, Norihisa, et al.
Publicado: (2015) -
THYMIDINE TRIPHOSPHATE SYNTHESIS IN TETRAHYMENA
: I. Studies on Thymidine Kinase
por: Shoup, G. D., et al.
Publicado: (1966) -
INDUCIBILITY OF THYMIDINE KINASE BY THYMIDINE AS A FUNCTION OF INTERPHASE STAGE
por: Hotta, Yasuo, et al.
Publicado: (1965) -
Thymidine kinase in breast cancer.
por: Robertson, J. F., et al.
Publicado: (1990)